BIOTECH ON THE MOVE! We are on the Nasdaq at the right time for mine.
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billionAbbVie's announcement of its $10.1 billion acquisition of cancer drug developer ImmunoGen led to a significant surge in Biotech Stocks.
- Forums
- ASX - By Stock
- IHL - INCANNEX - HOLDERS RESEARCH
BIOTECH ON THE MOVE! We are on the Nasdaq at the right time for...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)